Themis Medicare Ltd (THEM)

1,150.00
+39.00(+3.51%)
  • Volume:
    6,489
  • Bid/Ask:
    1,135.00/1,147.75
  • Day's Range:
    1,100.00 - 1,150.00

THEM Overview

Prev. Close
1,111
Day's Range
1,100-1,150
Revenue
2.75B
Open
1,124.5
52 wk Range
686.45-1,435.25
EPS
63.52
Volume
6,489
Market Cap
10.45B
Dividend (Yield)
5.00
(0.38%)
Average Vol. (3m)
5,920
P/E Ratio
17.95
Beta
0.701
1-Year Change
23.16%
Shares Outstanding
9,202,770
Next Earnings Date
May 31, 2023
What is your sentiment on Themis Medicare Ltd?
or
Market is currently closed. Voting is open during market hours.

Themis Medicare Ltd Company Profile

Themis Medicare Ltd Company Profile

Employees
1145
Market
India
  • Type:Equity
  • Market:India
  • ISIN:INE083B01016
  • S/N:THEMISMED

Themis Medicare Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical and medical chemicals products. The Company is focused on the formulation and active pharmaceutical ingredients (API) activity. Its product category includes star products, differential products, and APIs. Its star products include OD-LM (Levocetrizine 5 mg + Montelukast 10 mg), Medzol (Midazolam hydrochloride 1 ml, 5ml and 10 ml), Cisatra (Cisatracurium 2 mg/ml), and Aquadol (Diclofenac sodium 75mg/ml). Its differential products include Enterofizz-EL (Bacillus clausii + Electrolytes) and Etojet (Etoricoxib 90mg/ml). Its APIs products include Simvastatin, Ketamine Hcl, and Isosorbide Di Methyl Ether (THEMISOL).The Company’s manufacturing locations in India are situated at Vapi, Haridwar and Hyderabad. The Company markets in over 44 countries. Its subsidiaries include Artemis Biotech Limited, Themis Lifestyle Private Limited, and Carpo Medical Limited (UK).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Buy
  • very promising script but little discussed.
    0